NDC 0781-9221-91 - Clindamycin in 5 Percent Dextrose
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-9221
- Requested NDC
- 0781-9221-91
- Package NDCs from labels
- 0781-9221-91, 0781-9221-09
- Manufacturer
- Sandoz Inc
- Effective date
- 2022-06-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clindamycin in 5 Percent Dextrose - Sandoz Inc | Sandoz Inc | 2022-06-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-9221-09 | ML - Milliliter | 0781-9221 | e56cc72e-ded2-4be7-9da2-5c0afa964cc3 | 1 | 2014-08-01 |
| 0781-9221-91 | ML - Milliliter | 0781-9221 | 31dfbe40-36be-4234-8307-dbebf802cabf | 1 | 2018-03-08 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CLINDAMYCIN | ACTIVE INGREDIENT | 3U02EL437C | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 1 | |
| CLINDAMYCIN | ACTIVE MOIETY | 3U02EL437C | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 1 | |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LX22YL083G | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| STERILE CORD BLOOD COLLECTION UNIT (MSC123D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE | Maco Productions | e3b456ec-4578-485f-a696-8a343505f30b | 2025-12-16 | Warnings | LX22YL083G |
| Hemorrhoid | AESCULUS HIPP, HAMAMELIS, ALOE, CALC PHOS, CARBO AN, CARBO VEG, LACHESIS, LYCOPODIUM, MURIATICUM AC, NITRICUM AC, NUX VOM, PAEONIA, RATANHIA, SEPIA, SULPHUR | Natural Creations, Inc | db1b3aef-ba92-417c-b6f6-58e950ed4214 | 2025-12-16 | Warnings | QTT17582CB |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | ab19b011-0a51-4f04-9881-d9fc7cae95ae | 2025-11-25 | LX22YL083G | |
| Dextrose in Lactated Ringers | DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | 190da07e-a616-46e6-b4e5-1c0ba39306e5 | 2025-11-05 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | 8b25b7e0-703e-4b43-a4eb-52863511602d | 2025-11-02 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | ICU Medical Inc. | d8ee14e9-6733-4813-9f21-2b043a5f7188 | 2025-11-02 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | ICU Medical Inc. | 4555b1bf-6d97-4798-a63d-6d34291c85ce | 2025-11-02 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE | ICU Medical Inc. | b5cb7a5a-bbe8-4217-a82e-da818f7771c9 | 2025-11-02 | Warnings, Adverse reactions | LX22YL083G |
| Lactated Ringers and Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE | ICU Medical Inc. | d310d170-5eeb-471b-af1a-0e845001d21d | 2025-11-02 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | cb578dba-094c-4787-951d-763d12fd06e1 | 2025-11-01 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Lactated Ringers and Dextrose | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, AND DEXTROSE MONOHYDRATE | ICU Medical Inc. | 237b39fa-916e-4a54-99c8-4ae9ad54f056 | 2025-10-30 | Warnings, Adverse reactions | LX22YL083G |
| Normosol-R and Dextrose | DEXTROSE, SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | ICU Medical Inc. | ead1fca3-eff4-478f-8a8f-67510f80151a | 2025-10-30 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Dextrose | DEXTROSE MONOHYDRATE AND POTASSIUM CHLORIDE INJECTION, SOLUTION | ICU Medical Inc. | 02d694b5-3600-4d55-bd5c-924abaec5315 | 2025-10-30 | Warnings, Adverse reactions | LX22YL083G |
| Ionosol MB and Dextrose | DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ICU Medical Inc. | 1b457b1d-0e80-4578-ba6f-dedf513fc962 | 2025-10-30 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Lactated Ringers and Dextrose | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | 05f326e6-10e4-4ceb-8a23-f53c592f00b8 | 2025-10-29 | Warnings, Adverse reactions | LX22YL083G |
| Lactated Ringers and Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 6acc9f96-7088-45a7-b48f-1a861e3467ab | 2025-10-29 | Warnings, Adverse reactions | LX22YL083G |
| NORMOSOL-M AND DEXTROSE | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, POTASSIUM ACETATE, AND MAGNESIUM ACETATE | ICU Medical Inc. | aba60c84-94d9-46d0-bdbb-25e0c4e8cc41 | 2025-10-24 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical Inc. | cdf35d11-fbc8-4f8e-85a8-33220312c0b4 | 2025-10-17 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3eff8bcd-6a33-428f-e063-6394a90afa68 | 2025-09-17 | Warnings, Adverse reactions | LX22YL083G |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.